Medplus Health Services Subsidiary Faces Drug License Suspensions in Karnataka
Medplus Health Services Limited reported that its subsidiary, Optival Health Solutions Private Limited, has received two suspension orders regarding drug licenses for stores operating in the state of Karnataka.The suspensions were issued by the Drugs Control Administration, detailing violations under Rule 65 of the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The orders were received on April 16, 2026.
The company provided the following details regarding the licenses suspended in Karnataka:
| Location/Store | Suspension Duration | Potential Revenue Loss |
|---|---|---|
| Jayanagar 5th Block | Four days | Rs 3.68 lacs |
| Srinivasanagar Bsk 2nd Stage | Five days | Rs 1.30 lacs |
The suspension orders relate to violations under Rule 65 of the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The reported potential revenue losses for the two locations total Rs 4.98 lacs.
MEDPLUS Stock Price Movement
Today, Medplus Health Services Limited shares edged higher, closing at ₹877.8, marking a notable 1.12% gain for the day. The stock saw robust investor participation, trading a volume of 140,873 shares in post-market activity.Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.